The mutagenic forces shaping the genomes of lung cancer in never smokers
Marcos Díaz-Gay,
Tongwu Zhang,
Phuc H. Hoang,
Charles Leduc,
Marina K. Baine,
William D. Travis,
Lynette M. Sholl,
Philippe Joubert,
Azhar Khandekar,
Wei Zhao,
Christopher D. Steele,
Burçak Otlu,
Shuvro P. Nandi,
Raviteja Vangara,
Erik N. Bergstrom,
Mariya Kazachkova,
Oriol Pich,
Charles Swanton,
Chao Agnes Hsiung,
I-Shou Chang,
Maria Pik Wong,
Kin Chung Leung,
Jian Sang,
John P. McElderry,
Caleb Hartman,
Frank J. Colón-Matos,
Mona Miraftab,
Monjoy Saha,
Olivia W. Lee,
Kristine M. Jones,
Pilar Gallego-García,
Yang Yang,
Xiaoming Zhong,
Eric S. Edell,
Jacobo Martínez Santamaría,
Matthew B. Schabath,
Sai S. Yendamuri,
Marta Manczuk,
Jolanta Lissowska,
Beata Świątkowska,
Anush Mukeria,
Oxana Shangina,
David Zaridze,
Ivana Holcatova,
Dana Mates,
Sasa Milosavljevic,
Millica Kontic,
Yohan Bossé,
Bonnie E. Gould Rothberg,
David C. Christiani,
Valerie Gaborieau,
Paul Brennan,
Geoffrey Liu,
Paul Hofman,
Lixing Yang,
Martin A. Nowak,
Jianxin Shi,
Nathaniel Rothman,
David C. Wedge,
Robert Homer,
Soo-Ryum Yang,
Angela C. Pesatori,
Dario Consonni,
Qing Lan,
Bin Zhu,
Stephen J. Chanock,
Jiyeon Choi,
Ludmil B. Alexandrov () and
Maria Teresa Landi ()
Additional contact information
Marcos Díaz-Gay: University of California San Diego
Tongwu Zhang: National Cancer Institute
Phuc H. Hoang: National Cancer Institute
Charles Leduc: Centre Hospitalier de l’Université de Montréal
Marina K. Baine: Memorial Sloan Kettering Cancer Center
William D. Travis: Memorial Sloan Kettering Cancer Center
Lynette M. Sholl: Brigham and Women’s Hospital
Philippe Joubert: Institut Universitaire de Cardiologie et de Pneumologie de Québec – Université Laval
Azhar Khandekar: University of California San Diego
Wei Zhao: National Cancer Institute
Christopher D. Steele: University of California San Diego
Burçak Otlu: University of California San Diego
Shuvro P. Nandi: University of California San Diego
Raviteja Vangara: University of California San Diego
Erik N. Bergstrom: University of California San Diego
Mariya Kazachkova: University of California San Diego
Oriol Pich: Francis Crick Institute
Charles Swanton: Francis Crick Institute
Chao Agnes Hsiung: National Health Research Institutes
I-Shou Chang: National Health Research Institutes
Maria Pik Wong: University of Hong Kong
Kin Chung Leung: University of Hong Kong
Jian Sang: National Cancer Institute
John P. McElderry: National Cancer Institute
Caleb Hartman: National Cancer Institute
Frank J. Colón-Matos: National Cancer Institute
Mona Miraftab: National Cancer Institute
Monjoy Saha: National Cancer Institute
Olivia W. Lee: National Cancer Institute
Kristine M. Jones: National Cancer Institute
Pilar Gallego-García: Spanish National Cancer Research Center (CNIO)
Yang Yang: University of Chicago
Xiaoming Zhong: University of Chicago
Eric S. Edell: Mayo Clinic
Jacobo Martínez Santamaría: Biobanco IBSP-CV FISABIO
Matthew B. Schabath: H. Lee Moffitt Cancer Center and Research Institute
Sai S. Yendamuri: Roswell Park Comprehensive Cancer Center
Marta Manczuk: Maria Skłodowska-Curie National Research Institute of Oncology
Jolanta Lissowska: Maria Skłodowska-Curie National Research Institute of Oncology
Beata Świątkowska: Nofer Institute of Occupational Medicine
Anush Mukeria: N.N. Blokhin National Medical Research Centre of Oncology
Oxana Shangina: N.N. Blokhin National Medical Research Centre of Oncology
David Zaridze: N.N. Blokhin National Medical Research Centre of Oncology
Ivana Holcatova: Charles University
Dana Mates: National Institute of Public Health
Sasa Milosavljevic: International Organization for Cancer Prevention and Research (IOCPR)
Millica Kontic: Clinical Center of Serbia
Yohan Bossé: Institut Universitaire de Cardiologie et de Pneumologie de Québec – Université Laval
Bonnie E. Gould Rothberg: University of Miami Miller School of Medicine
David C. Christiani: Harvard T.H. Chan School of Public Health
Valerie Gaborieau: International Agency for Research on Cancer (IARC/WHO)
Paul Brennan: International Agency for Research on Cancer (IARC/WHO)
Geoffrey Liu: University of Toronto
Paul Hofman: Côte d’Azur University
Lixing Yang: University of Chicago
Martin A. Nowak: Harvard University
Jianxin Shi: National Cancer Institute
Nathaniel Rothman: National Cancer Institute
David C. Wedge: University of Manchester
Robert Homer: Yale School of Medicine
Soo-Ryum Yang: Memorial Sloan Kettering Cancer Center
Angela C. Pesatori: University of Milan
Dario Consonni: Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico
Qing Lan: National Cancer Institute
Bin Zhu: National Cancer Institute
Stephen J. Chanock: National Cancer Institute
Jiyeon Choi: National Cancer Institute
Ludmil B. Alexandrov: University of California San Diego
Maria Teresa Landi: National Cancer Institute
Nature, 2025, vol. 644, issue 8075, 133-144
Abstract:
Abstract Lung cancer in never smokers (LCINS) accounts for around 25% of all lung cancers1,2 and has been associated with exposure to second-hand tobacco smoke and air pollution in observational studies3–5. Here we use data from the Sherlock-Lung study to evaluate mutagenic exposures in LCINS by examining the cancer genomes of 871 treatment-naive individuals with lung cancer who had never smoked, from 28 geographical locations. KRAS mutations were 3.8 times more common in adenocarcinomas of never smokers from North America and Europe than in those from East Asia, whereas a higher prevalence of EGFR and TP53 mutations was observed in adenocarcinomas of never smokers from East Asia. Signature SBS40a, with unknown cause6, contributed the largest proportion of single base substitutions in adenocarcinomas, and was enriched in cases with EGFR mutations. Signature SBS22a, which is associated with exposure to aristolochic acid7,8, was observed almost exclusively in patients from Taiwan. Exposure to secondhand smoke was not associated with individual driver mutations or mutational signatures. By contrast, patients from regions with high levels of air pollution were more likely to have TP53 mutations and shorter telomeres. They also exhibited an increase in most types of mutations, including a 3.9-fold increase in signature SBS4, which has previously been linked with tobacco smoking9, and a 76% increase in the clock-like10 signature SBS5. A positive dose–response effect was observed with air-pollution levels, correlating with both a decrease in telomere length and an increase in somatic mutations, mainly attributed to signatures SBS4 and SBS5. Our results elucidate the diversity of mutational processes shaping the genomic landscape of lung cancer in never smokers.
Date: 2025
References: Add references at CitEc
Citations:
Downloads: (external link)
https://www.nature.com/articles/s41586-025-09219-0 Abstract (text/html)
Access to the full text of the articles in this series is restricted.
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:644:y:2025:i:8075:d:10.1038_s41586-025-09219-0
Ordering information: This journal article can be ordered from
https://www.nature.com/
DOI: 10.1038/s41586-025-09219-0
Access Statistics for this article
Nature is currently edited by Magdalena Skipper
More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().